Search Within

Henry Stuart Walch

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (11)
Groups
  1. Department of Medicine (25)
  2. Genitourinary Oncology Service (25)
  3. Human Oncology and Pathogenesis Program (25)
  4. Solid Tumor Oncology Division (25)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (24)
  6. Department of Pathology and Laboratory Medicine (24)

More Groups

People
  1. David Solit (23)
  2. Nikolaus Schultz (20)
  3. Walid Chatila (20)
  4. Michael Berger (17)
  5. Yelena Janjigian (10)
  6. Jinru Shia (9)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (5)
  6. 2019 (1)
Publications
  1. Journal of Clinical Oncology (9)
  2. Clinical Cancer Research (3)
  3. Cancer Research (2)
  4. JCO Precision Oncology (2)
  5. Nature Medicine (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (5)
  3. Nature Publishing Group (3)
  4. Oxford University Press (3)
  5. Cell Press (1)
  6. Elsevier BV (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies
    Meeting Abstract

    Thummalapalli, R.; Darmofal, M.; Seier, K.; Khalil, D. N.; Walch, H. S.; Shia, J.; Park, W.; El Dika, I. H.; Chatila, W. K.; Schultz, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Journal Article

    Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Genomic profiling of bladder cancer in waterpipe and cigarette smokers: Implications for carcinogenicity and genetic landscape
    Meeting Abstract

    Shamseddine, A.; Abbas, N.; Chatila, W. K.; Walch, H. S.; Eichholz, J.; Schultz, N.; Solit, D. B.; Charafeddine, M.; Al Darazi, M.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Phu, W.; Shah, R. H.; Walch, H. S.; Chatila, W. K.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Srivastava, A.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Meeting Abstract

    Cowzer, D.; Capanu, M.; Keane, F.; Khalil, D.; Shia, J.; Do, R.; Chou, J.; Walch, H.; El Dika, I.; Yaqubie, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save